Brand & retailer Initiatives Database To help keep track of the global shift towards chemically safe and more resource-conscious food packaging, the Food Packaging Forum has developed a database of voluntary initiatives and commitments by food brands and retailers About the database In an effort to improve the chemical safety and resource efficiency of the food contact materials (FCMs) and articles (FCAs) they use, food brands and retailers from around the world have gone beyond legal requirements by launching hundreds […]
Scientists evaluate health effects of a mixture of 27 environmental chemicals in rats exposed to low concentrations comparable to current human exposure levels; find effects on weight, histology, gene expression in the liver, and metabolome of blood plasma
New study assesses reliability of standardized Benchmark Dose calculations, more dose groups and lower number of animals make for better BMD model
Scientists discuss different cases of nonmonotonic dose-response curves and their relevance for regulatory decision-making; nonmonotonicity occurring at low doses challenges current approach to determining low-dose ‘safe’ exposure levels from high-dose toxicity testing
New study investigates effects of prenatal BPA exposure on metabolism in vivo
The process of chemical risk assessment: Hazard identification, dose-response assessment, exposure assessment and hazard characterization
The application of engineered nanomaterials in food contact materials is considered promising tool to improve functionality, but knowledge about exposure and toxicity remains limited. The Food Packaging Forum reviews applications, exposure, toxicity and regulation of nanomaterials.
New epidemiological study finds association between high PFOA contamination in drinking water and kidney and testicular cancer, confirming earlier research
In-depth review of low-dose effects of hormones and endocrine disrupting chemicals and their implications for risk assessment
Hormones are special. They cause certain effects only at low doses, while at higher doses different or even opposite outcomes are observed. Endocrine disrupting chemicals (EDCs) can also behave like hormones by activating typical hormone pathways. They, too, can do this differentially, depending on their dose. The science around EDCs is becoming clearer.